1[1]Yeo KT,Wang HH,Nagy JA.Vascular pemeability factor(vascular endotheliar growth tactor)in guinea pig and human tumor and inflammatory effusions.Cancer Res,1993,2912
2[2]Nanus DM,Schmitz-Drager BJ,Motzer RL,et al.Expression of basic fibroblast growth factor in primary human renaltumor.J Nal Cancer Inst,1993,85:1597
3[3]Claffer KP,Robinson GS.Regulation of VEGFNPF expression in tumor cells:consequences for tumor growth and metastasis.Cancer Metastasis Rev,1996,15:165
4[4]Hanahan D,Folkman J.Pettems and emerging mechanism of angiogenic switch during tumorigenesis.Cell,1996,86:33
5[5]O'Reilly MS,Boehm T,Shing Y,et al.Cell,Endostatin:an endogenous inhibitor of angiogenesis and tumor growth cells，1997，88:1－20
6[6]Rastindjad F,Polverini PJ,Bouck NP,et al.Cell,regulation of the activity of a new inhibitor of angiogenesis by a cancer supressior.1989,56:345
7[7]Lezekowitz RBA,Mulliken JB,Folkman J,et al.Interferon alpha 2a therapy for life threatenting hemangiomas of infancy.J Med,1992,326:1456
8[8]Wojtowiez-Praga S,Low J,Marshall J,et al.Phase I trial of a novel matrix metalloproteinase inhibitor batimastat(BB-94)in patients with advanced cancer.Invest New Drugs,1996,14:193
9[9]Pasqualini R,Koivunen E,Ruoslahti E,et al.Alpha-V integrins as receptors for tumor targeting by circulating ligands.Nat Biotechnol,1997,15:42
10[10]O' Reilly MS,Homgren L,Shing Y,et al.Cell,angiostatin:a noval angiogenesis inhibitor that metastases by a lewis lung carcinoma.Cell,1994,79:315
